Results

Total Results: 1,426 records

Showing results for "stage".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/field-triage-glascow-disposition-170415.pdf
    January 12, 2017 - Peer Reviewer #1 Introduction appropriately sets the stage for the review Thank you.
  2. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/aggression_research-protocol.pdf
    October 05, 2015 - The use of restrictive interventions, such as restraints, at this early stage may only further escalate
  3. effectivehealthcare.ahrq.gov/products/distributed-network-safety/research
    July 28, 2009 - Design Specifications for Network Prototype and Cooperative To Conduct Population-Based Studies and Safety Surveillance Research Report July 28, 2009 Download Main Document PDF 547.9 KB Author Affiliations Jeffrey Brown, Ph.D. a John Holmes, Ph.D. b Judy Maro, B.A., B.S. c Beth Syat, M.P.H. a Kim…
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
    April 01, 2022 - Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
    April 25, 2013 - duration, escalation), Hb (baseline, and all recorded values preferably at times specified by protocol), stage … considering the risks-benefits of ESA therapy in the context of a specific patient, with a specific type and stage … Page 100, line 56, 57: inserted text ‘by’ Page 101, line 18: inserted text ‘stage of malignancy, treatment … The BEST study enrolled patients with similar tumor type and stage, but allowed any chemotherapy regimen … Untch et al (n = 729), respectively, both enrolled a patient population with similar tumor type and stage
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
    December 01, 2012 - Treatment of Colorectal Cancer The diagnosis of CRC requires pathologic review to characterize and stage … I, 64.5 percent for stage IIA, 51.6 percent for stage IIB, 32.3 percent for stage IIC, 74 percent for … IIIA, 45 percent for IIIB, 33.4 percent for IIIC, and 6 percent for stage IV.9 Survival declines … with increasing depth of tumor penetration, increasing tumor stage, and patient age. … Patients with stage III colon cancer who received postsurgical FOLFOX chemotherapy had a 3-year survival
  7. S5 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
    October 01, 2007 - methods, patient safety, pharmaceuticals, research, statistics (Med Care 2007;45: S5–S8) SETTING THE STAGE
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
    June 12, 2013 - Source: www.effectivehealthcare.ahrq.gov Published online: June 12, 2013 Evidence-based Practice Center Systematic Review Protocol Project Title: Menopausal Symptoms: Comparative Effectiveness Review of Therapies Original  Date  of  Protocol:  April  3,  2012   Amendment  Date:  June  5, …
  9. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-in-the-postpartum-period-what-is-the-effectiveness-and-safety-of-screening-and-treatment-for-depression-please-use-the-uspstf-framework-which-considers-not-only-screening-but-followup-treatment-and-management-the-tr
    October 01, 2011 - (For example, an ethnic group, stage or severity of a disease.)
  10. effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-clin-summary.pdf
    March 01, 2016 - detection and treatment is ideal, only 15 percent of lung cancer cases are diagnosed at an early stage
  11. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/measurement-and-outcomes-need-consensus-definitions-state-medicaid-programs-need-robust-hedis-and-ncqa-measures-for-all-severe-and-persistent-mental-health-conditions-consensus-definitions-would-help-answer-questions-such-as-
    November 23, 2010 - (For example, an ethnic group, stage or severity of a disease.)
  12. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-clin-summary.pdf
    March 01, 2016 - detection and treatment is ideal, only 15 percent of lung cancer cases are diagnosed at an early stage
  13. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/the-american-college-of-chest-physicians-accp-proposes-to-update-the-following-4-guideline-topics-from-the-2006-publication-on-the-diagnosis-and-management-of-cough-accp-evidence-based-clinical-practice-guidelines1-1-assessin
    January 01, 2006 - (For example, an ethnic group, stage or severity of a disease.)
  14. effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research-protocol
    May 07, 2010 - failure, cerebral vascular disease or events [including stroke], symptomatic coronary artery disease, end-stage … the current search strategy and initial number of abstracts to be included in our abstract screening stage
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
    October 01, 2014 - It is refreshing to see concerns of patient anxiety and quality of life sharing the stage with the … That is, changes in therapeutic management or stage reclassification are appropriate terminal points
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
    June 01, 2010 - consultation with clinical experts may also identify important gaps in the RCT evidence at the protocol stage … registry in the United States that enrolls patients who have received ventricular assist devices for end-stage … Well-known or large RCTs should be examined in detail at this stage.
  17. effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and … Hoskin, 201219 -- n = 218 EBRT: n = 108 EBRT + high- dose-rate brachytherapy boost: n = 110 Stage … Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and … Hoskin, 201219 -- n = 218 EBRT: n = 108 EBRT + high- dose-rate brachytherapy boost: n = 110 Stage … Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and
  19. effectivehealthcare.ahrq.gov/products/cancer-quality-indicator-testing/research
    May 19, 2010 - the cancer registry to identify patients diagnosed in 2006 with one of the following tumor types and stage … At JHH/SKCCC, the cancer registry identified patients with stage IV lung, pancreatic, breast, and colorectal … cancer (and Stage IIIB for lung cancer) disease in 2003-2005 who died 2-15 months after diagnosis.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
    November 03, 2014 - Therefore primary care physicians (PCPs) and emergency physicians are well-positioned to diagnose early-stage … Full-text articles will be dually reviewed; disagreements regarding inclusion at the full-text stage … comorbidities, we will determine whether studies report factors such as sex, duration of the condition, and stage

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: